Yu Sun Chen

US Patent:

6713329, Mar 30, 2004

Filed:

Mar 6, 2002

Appl. No.:

10/030371

Inventors:

Sigurd Wagner - Princeton NJ
Yu Chen - Milpitas CA

Assignee:

The Trustees of Princeton University - Princeton NJ

International Classification:

H01L 2100

US Classification:

438154, 438151, 438153, 157 64, 157347

Abstract:

A p channel thin-film transistor (TFT) made of directly deposited microcrystalline silicon (uc-Si). The p TFT is integrated with its n channel counterpart on a single uc-Si film, to form a complementary metal-silicon oxide-silicon (CMOS) inverter of deposited uc-Si. The uc-Si channel material can be grown at lower temperatures by plasma-enhanced chemical vapor deposition in a process similar to the deposition. The p and n channels share the same uc-Si layer. The Figure shows the processing steps of manufacturing the TFT, where ( ) represents the uc-Si layer of the device.

US Patent:

7091396, Aug 15, 2006

Filed:

Oct 17, 2001

Appl. No.:

09/982120

Inventors:

Sanford M. Simon - New York NY, US
Yu Chen - New York NY, US

Assignee:

The Rockefeller University - New York NY

International Classification:

A01K 67/027
A01K 67/033
C12N 15/63
C12N 5/06
C12N 5/10

US Classification:

800 18, 800 13, 435326, 435325, 435455, 4353201

Abstract:

Genetically-modified mammals and immune cells are provided which are capable of producing or secreting detectably-labeled immunoglobulin molecules as a result of genetic modifications of at least one immunoglobulin gene in the genome thereof, such that a fusion polynucleotide encoding a detectable protein or peptide and an immunoglobulin component molecule is present.

US Patent:

20030049597, Mar 13, 2003

Filed:

Mar 1, 2001

Appl. No.:

09/797496

Inventors:

Sanford Simon - New York NY, US
Yu Chen - New York NY, US

International Classification:

C12Q001/00
C12Q001/37
C12N015/87

US Classification:

435/004000, 435/023000, 435/455000

Abstract:

Method for similtaneously quantifying in situ the relationship between an enzyme and its substrate, especially by the use of fluorescence.

US Patent:

20040229412, Nov 18, 2004

Filed:

Dec 24, 2003

Appl. No.:

10/746945

Inventors:

Sigurd Wagner - Princeton NJ, US
Yu Chen - Pearland TX, US

International Classification:

H01L021/00
H01L021/84

US Classification:

438/154000

Abstract:

A p channel thin-film transistor (TFT) made of directly deposited microcrystalline silicon (c-Si). The p TFT is integrated with its n channel counterpart on a single c-Si film, to form a complementary metal-silicon oxide-silicon (CMOS) inverter of deposited c-Si. The c-Si channel material can be grown at lower temperatures by plasma-enhanced chemical vapor deposition in a process similar to the deposition of hydrogenated amorphous silicon. The p and n channels share the same c-Si layer.

US Patent:

20060288430, Dec 21, 2006

Filed:

Jun 23, 2006

Appl. No.:

11/474133

Inventors:

Sanford Simon - New York NY, US
Yu Chen - New York NY, US

International Classification:

A01K 67/027

US Classification:

800006000, 800014000

Abstract:

Genetically-modified mammals and immune cells are provided which are capable of producing or secreting detectably-labeled immunoglobulin molecules as a result of genetic modifications of at least one immunoglobulin gene in the genome thereof, such that a fusion polynucleotide encoding a detectable protein or peptide and an immunoglobulin component molecule is present.

US Patent:

20090193530, Jul 30, 2009

Filed:

Dec 12, 2008

Appl. No.:

12/316433

Inventors:

Sanford M. Simon - New York NY, US
Yu Chen - New York NY, US

International Classification:

A01K 67/027
C12N 15/85
C12N 5/06
C07K 16/18

US Classification:

800 6, 800 14, 435328, 5303917

Abstract:

Genetically-modified mammals and immune cells are provided which are capable of producing or secreting detectably-labeled immunoglobulin molecules as a result of genetic modifications of at least one immunoglobulin gene in the genome thereof, such that a fusion polynucleotide encoding a detectable protein or peptide and an immunoglobulin component molecule is present.

US Patent:

62040677, Mar 20, 2001

Filed:

Jun 17, 1999

Appl. No.:

9/335457

Inventors:

Sanford M. Simon - New York NY
Melvin S. Schindler - Okemos MI
Yu Chen - New York NY

Assignee:

Board of Trustees Operating Michigan State University - East Lansing MI

International Classification:

G01N 3122
G01N 2180
G01N 3348
C07C21104

US Classification:

436163

Abstract:

The present invention discloses the mechanism of tamoxifen mediated inhibition of acidification. This mechanism information is then used to design methods of identifying compounds that will have the pharmaceutical effect of tamoxifen without the corresponding side-effects.

US Patent:

20230095706, Mar 30, 2023

Filed:

Nov 7, 2022

Appl. No.:

18/053363

Inventors:

- Atlanta GA, US
Wenjie Zhao - Princeton NJ, US
Ganesh Krishnamurthi - Danville CA, US
Huahui Wang - Bridgewater NJ, US
Huijing Yang - Princeton NJ, US
Yu Chen - Pittsburgh PA, US

International Classification:

G06N 3/08
G06N 3/04
H04W 24/08

Abstract:

A processing system including at least one processor may obtain operational data from a radio access network (RAN), format the operational data into state information and reward information for a reinforcement learning agent (RLA), processing the state information and the reward information via the RLA, where the RLA comprises a plurality of sub-agents, each comprising a respective neural network, each of the neural networks encoding a respective policy for selecting at least one setting of at least one parameter of the RAN to increase a respective predicted reward in accordance with the state information, and where each neural network is updated in accordance with the reward information. The processing system may further determine settings for parameters of the RAN via the RLA, where the RLA determines the settings in accordance with selections for the settings via the plurality of sub-agents, and apply the plurality of settings to the RAN.